The pro-inflammatory activity of
Tumor necrosis factor-alpha (
TNF-alpha) together with tissue
hypoxia determine the clinical outcome in
sepsis and
septic shock. p38 MAPKinase is the primary intracellular signaling pathway that regulates
lipopolysaccharide (LPS)-induced
TNF-alpha biosynthesis, however, the effect of
hypoxia on LPS mediated activation of p38 is not known. Here we report that
SB203580, a specific
p38 MAPK inhibitor, which completely abolished LPS-induced
TNF-alpha expression by the mouse macrophage cell RAW264.7 in normoxic conditions, lost the inhibitory effect in hypoxic conditions.
Hypoxia did not modulate expression of
p38 MAPK, but increased that of p-MK2, a downstream target of
p38 MAPK. In LPS induced
endotoxemia mice model
SB203580 had no inhibitory effect on the serum levels of
TNF-alpha. Furthermore,
hypoxia inducible factor-1alpha (HIF-1alpha) was detected in vivo after LPS administration but its expression was not affected by
SB203580. Our data indicate that LPS induced
p38 MAPK activation was enhanced by
hypoxia and consequently increased
TNF-alpha secretion. Furthermore, the induction of HIF-1alpha in mice with
endotoxemia suggested a synergistic effect on p38 mediated
TNF-alpha expression. These findings provide new insights on the pathophysiological effects of
hypoxia in
sepsis and
septic shock.